 | | A4A | | Name: | [1,3]benzodioxolo[6,5,4-cd]benzo[f]indol-5(6H)-one | | Formula: | C16 H9 N O3 | | SMILES: | O=C3Nc4c2c(c1OCOc1cc23)c5c(c4)cccc5 | | InChi: | InChI=1S/C16H9NO3/c18-16-10-6-12-15(20-7-19-12)14-9-4-2-1-3-8(9)5-11(17-16)13(10)14/h1-6H,7H2,(H,17,18) | | Synonyms: | Aristolactam II | | Definition date: | 2011-08-03 | | Last modified: | 2020-06-17 | | Identifier: | [1,3]benzodioxolo[6,5,4-cd]benzo[f]indol-5(6H)-one |
|
 | | A4F | | Name: | 5-amino-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid | | Formula: | C20 H13 N O5 | | SMILES: | OC(c1cc(N)ccc1C2=C4C=CC(C=C4Oc3c2ccc(c3)O)=O)=O | | InChi: | InChI=1S/C20H13NO5/c21-10-1-4-13(16(7-10)20(24)25)19-14-5-2-11(22)8-17(14)26-18-9-12(23)3-6-15(18)19/h1-9,22H,21H2,(H,24,25) | | Synonyms: | 5-aminofluorescein | | Definition date: | 2015-05-20 | | Last modified: | 2020-06-17 | | Release date: | 2015-11-04 | | Identifier: | 5-amino-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid |
|
 | | A4S | | Name: | (2E,6E)-3,7-dimethyl-8-(phenylamino)octa-2,6-dien-1-yl trihydrogen diphosphate | | Formula: | C16 H25 N O7 P2 | | SMILES: | O=P(O)(O)OP(=O)(O)OC/C=C(C)CC/C=C(/CNc1ccccc1)C | | InChi: | InChI=1S/C16H25NO7P2/c1-14(11-12-23-26(21,22)24-25(18,19)20)7-6-8-15(2)13-17-16-9-4-3-5-10-16/h3-5,8-11,17H,6-7,12-13H2,1-2H3,(H,21,22)(H2,18,19,20)/b14-11+,15-8+ | | Synonyms: | anilinogeranyl diphosphate | | Definition date: | 2014-11-04 | | Last modified: | 2020-06-17 | | Release date: | 2015-05-06 | | Identifier: | (2E,6E)-3,7-dimethyl-8-(phenylamino)octa-2,6-dien-1-yl trihydrogen diphosphate |
|
 | | A54 | | Name: | 2-[(1R)-3-amino-1-phenyl-propoxy]-4-chloro-benzonitrile | | Formula: | C16 H15 Cl N2 O | | SMILES: | NCC[CH](Oc1cc(Cl)ccc1C#N)c2ccccc2 | | InChi: | InChI=1S/C16H15ClN2O/c17-14-7-6-13(11-19)16(10-14)20-15(8-9-18)12-4-2-1-3-5-12/h1-7,10,15H,8-9,18H2/t15-/m1/s1 | | Synonyms: | AR-C141954 | | Definition date: | 2010-12-19 | | Last modified: | 2020-06-17 | | Identifier: | 2-[(1R)-3-amino-1-phenyl-propoxy]-4-chloro-benzonitrile |
|
 | | A5F | | Name: | N-[(2S)-3-azanyl-3-methyl-1-(oxidanylamino)-1-oxidanylidene-butan-2-yl]-4-[4-[(1R,2R)-2-(hydroxymethyl)cyclopropyl]buta
-1,3-diynyl]benzamide | | Formula: | C20 H23 N3 O4 | | SMILES: | CC(C)(N)[CH](NC(=O)c1ccc(cc1)C#CC#C[CH]2C[CH]2CO)C(=O)NO | | InChi: | InChI=1S/C20H23N3O4/c1-20(2,21)17(19(26)23-27)22-18(25)14-9-7-13(8-10-14)5-3-4-6-15-11-16(15)12-24/h7-10,15-17,24,27H,11-12,21H2,1-2H3,(H,22,25)(H,23,26)/t15-,16+,17-/m1/s1 | | Synonyms: | ACHN-975 | | Definition date: | 2018-10-02 | | Last modified: | 2020-06-17 | | Release date: | 2019-01-30 | | Identifier: | ~{N}-[(2~{S})-3-azanyl-3-methyl-1-(oxidanylamino)-1-oxidanylidene-butan-2-yl]-4-[4-[(1~{R},2~{R})-2-(hydroxymethyl)cyclopropyl]buta-1,3-diynyl]benzamide |
|
 | | A5L | | Name: | 9-(2-deoxy-2-fluoro-5-O-phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine | | Formula: | C10 H13 F N5 O6 P | | SMILES: | O=P(O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(F)C3O | | InChi: | InChI=1S/C10H13FN5O6P/c11-5-7(17)4(1-21-23(18,19)20)22-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17H,1H2,(H2,12,13,14)(H2,18,19,20)/t4-,5+,7-,10-/m1/s1 | | Synonyms: | 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL ADENINE-5'-PHOSPHATE | | Definition date: | 2009-10-21 | | Last modified: | 2020-06-17 | | Identifier: | 9-(2-deoxy-2-fluoro-5-O-phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine |
|
 | | A6G | | Name: | 2-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-1,5-anhydro-2-deoxy-6-O-phosphono-D-altritol | | Formula: | C11 H16 N5 O8 P | | SMILES: | O=P(O)(O)OCC3OCC(n2cnc1c2N=C(N)NC1=O)C(O)C3O | | InChi: | InChI=1S/C11H16N5O8P/c12-11-14-9-6(10(19)15-11)13-3-16(9)4-1-23-5(8(18)7(4)17)2-24-25(20,21)22/h3-5,7-8,17-18H,1-2H2,(H2,20,21,22)(H3,12,14,15,19)/t4-,5-,7+,8-/m1/s1 | | Synonyms: | ((2R,3S,4S,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)methyl dihydrogen phosphate | | Definition date: | 2010-08-26 | | Last modified: | 2020-06-17 | | Identifier: | 2-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-1,5-anhydro-2-deoxy-6-O-phosphono-D-altritol |
|
 | | A6L | | Name: | 2,3-dihydroxypropyl (9Z)-octadec-9-enoate | | Formula: | C21 H40 O4 | | SMILES: | C(C(OCC(CO)O)=O)CCCCCCC=C/CCCCCCCC | | InChi: | InChI=1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h9-10,20,22-23H,2-8,11-19H2,1H3/b10-9- | | Synonyms: | monoolein | | Definition date: | 2018-10-02 | | Last modified: | 2020-06-17 | | Release date: | 2019-02-13 | | Identifier: | 2,3-dihydroxypropyl (9Z)-octadec-9-enoate |
|
 | | A70 | | Name: | N-ethyl-N-[(4-methylpiperazin-1-yl)carbonyl]-D-phenylalanyl-N-[(1S,2S,4R)-4-(butylcarbamoyl)-1-(cyclohexylmethyl)-2-hyd
roxy-5-methylhexyl]-L-norleucinamide | | Formula: | C42 H70 N6 O5 | | SMILES: | O=C(N1CCN(C)CC1)N3C(C(=O)N(C(C(=O)NC(CC2CCCCC2)C(O)CC(C(=O)NCCCC)C(C)C)CCCC)CC3)Cc4ccccc4 | | InChi: | InChI=1S/C42H70N6O5/c1-6-8-20-36(40(51)44-35(28-32-16-12-10-13-17-32)38(49)30-34(31(3)4)39(50)43-21-9-7-2)47-26-27-48(42(53)46-24-22-45(5)23-25-46)37(41(47)52)29-33-18-14-11-15-19-33/h11,14-15,18-19,31-32,34-38,49H,6-10,12-13,16-17,20-30H2,1-5H3,(H,43,50)(H,44,51)/t34-,35-,36-,37+,38-/m0/s1 | | Synonyms: | A70450 | | Definition date: | 1999-07-08 | | Last modified: | 2020-06-17 | | Identifier: | (2S,4S,5S)-5-{[(2S)-2-{(3R)-3-benzyl-4-[(4-methylpiperazin-1-yl)carbonyl]-2-oxopiperazin-1-yl}hexanoyl]amino}-N-butyl-6-cyclohexyl-4-hydroxy-2-(1-methylethyl)hexanamide |
|
 | | A7S | | Name: | 1-(3-fluoro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide | | Formula: | C20 H23 F N2 O3 S | | SMILES: | c1(cc(F)c(C)cc1)CS(Nc3cc2CCC(N(CCC)c2cc3)=O)(=O)=O | | InChi: | InChI=1S/C20H23FN2O3S/c1-3-10-23-19-8-7-17(12-16(19)6-9-20(23)24)22-27(25,26)13-15-5-4-14(2)18(21)11-15/h4-5,7-8,11-12,22H,3,6,9-10,13H2,1-2H3 | | Synonyms: | AMF1beta | | Definition date: | 2017-07-10 | | Last modified: | 2020-06-17 | | Release date: | 2017-11-15 | | Identifier: | 1-(3-fluoro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide |
|
 | | A86 | | Name: | (3S,3'S,5R,5'R,6S,6'R,8'R)-3,5'-dihydroxy-8-oxo-6',7'-didehydro-5,5',6,6',7,8-hexahydro-5,6-epoxy-beta,beta-caroten-3'-
yl acetate | | Formula: | C42 H58 O6 | | SMILES: | CC(=C/C=C/C=C(/C=C/C=C(C)C(=O)CC12C(C)(CC(O)CC1(C)O2)C)C)[C@H]=C[C@H]=C([C@H]=C=C3C(C)(C)CC(CC3(O)C)OC(=O)C)C | | InChi: | InChI=1S/C42H58O6/c1-29(18-14-19-31(3)22-23-37-38(6,7)26-35(47-33(5)43)27-40(37,10)46)16-12-13-17-30(2)20-15-21-32(4)36(45)28-42-39(8,9)24-34(44)25-41(42,11)48-42/h12-22,34-35,44,46H,24-28H2,1-11H3/b13-12+,18-14+,20-15+,29-16+,30-17+,31-19+,32-21+/t23-,34-,35-,40+,41+,42-/m0/s1 | | Synonyms: | Fucoxanthin | | Definition date: | 2018-10-17 | | Last modified: | 2020-06-17 | | Release date: | 2019-02-06 | | Identifier: | (3S,3'S,5R,5'R,6S,6'R,8'R)-3,5'-dihydroxy-8-oxo-6',7'-didehydro-5,5',6,6',7,8-hexahydro-5,6-epoxy-beta,beta-caroten-3'-yl acetate |
|
 | | A8B | | Name: | N-QUINOLIN-4-YL-N'-(1,2,3,4-TETRAHYDROACRIDIN-9-YL)OCTANE-1,8-DIAMINE | | Formula: | C30 H36 N4 | | SMILES: | n2c1c(cccc1)c(cc2)NCCCCCCCCNc3c5c(nc4c3CCCC4)cccc5 | | InChi: | InChI=1S/C30H36N4/c1(3-11-20-31-27-19-22-32-26-16-8-5-13-23(26)27)2-4-12-21-33-30-24-14-6-9-17-28(24)34-29-18-10-7-15-25(29)30/h5-6,8-9,13-14,16-17,19,22H,1-4,7,10-12,15,18,20-21H2,(H,31,32)(H,33,34) | | Synonyms: | TACRINE(8)-4-AMINOQUINOLINE | | Definition date: | 2003-02-15 | | Last modified: | 2020-06-17 | | Identifier: | N-quinolin-4-yl-N'-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine |
|
 | | A8W | | Name: | Pregnenolone sulfate | | Formula: | C21 H32 O5 S | | SMILES: | CC(=O)[CH]1CC[CH]2[CH]3CC=C4C[CH](CC[C]4(C)[CH]3CC[C]12C)O[S](O)(=O)=O | | InChi: | InChI=1S/C21H32O5S/c1-13(22)17-6-7-18-16-5-4-14-12-15(26-27(23,24)25)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19H,5-12H2,1-3H3,(H,23,24,25)/t15-,16-,17+,18-,19-,20-,21+/m0/s1 | | Synonyms: | pregn-5-en-3beta-ol-20-one-3beta-sulfate | | Definition date: | 2017-08-17 | | Last modified: | 2020-06-17 | | Release date: | 2017-10-11 | | Identifier: | [(3~{S},8~{S},9~{S},10~{R},13~{S},14~{S},17~{S})-17-ethanoyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1~{H}-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate |
|
 | | A8X | | Name: | 3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid | | Formula: | C21 H21 F N2 O4 S | | SMILES: | OC(=O)CCn1c2CC[CH](Cc2c3ccccc13)N[S](=O)(=O)c4ccc(F)cc4 | | InChi: | InChI=1S/C21H21FN2O4S/c22-14-5-8-16(9-6-14)29(27,28)23-15-7-10-20-18(13-15)17-3-1-2-4-19(17)24(20)12-11-21(25)26/h1-6,8-9,15,23H,7,10-13H2,(H,25,26)/t15-/m1/s1 | | Synonyms: | Ramatroban | | Definition date: | 2018-10-23 | | Last modified: | 2020-06-17 | | Release date: | 2018-12-19 | | Identifier: | 3-[(3~{R})-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid |
|
 | | A90 | | Name: | 2-[4-[2-[(4-chlorophenyl)sulfonylamino]ethyl]phenyl]ethanoic acid | | Formula: | C16 H16 Cl N O4 S | | SMILES: | OC(=O)Cc1ccc(CCN[S](=O)(=O)c2ccc(Cl)cc2)cc1 | | InChi: | InChI=1S/C16H16ClNO4S/c17-14-5-7-15(8-6-14)23(21,22)18-10-9-12-1-3-13(4-2-12)11-16(19)20/h1-8,18H,9-11H2,(H,19,20) | | Synonyms: | Daltroban | | Definition date: | 2018-10-23 | | Last modified: | 2020-06-17 | | Release date: | 2018-12-19 | | Identifier: | 2-[4-[2-[(4-chlorophenyl)sulfonylamino]ethyl]phenyl]ethanoic acid |
|
 | | A95 | | Name: | N-(4-(((4-(4-methoxyphenyl)oxan-4- yl)methyl)carbamoyl)phenyl)furan-2-carboxamide | | Formula: | C25 H26 N2 O5 | | SMILES: | COc1ccc(cc1)C2(CCOCC2)CNC(=O)c3ccc(NC(=O)c4occc4)cc3 | | InChi: | InChI=1S/C25H26N2O5/c1-30-21-10-6-19(7-11-21)25(12-15-31-16-13-25)17-26-23(28)18-4-8-20(9-5-18)27-24(29)22-3-2-14-32-22/h2-11,14H,12-13,15-17H2,1H3,(H,26,28)(H,27,29) | | Synonyms: | JW55 Inhibitor | | Definition date: | 2015-08-24 | | Last modified: | 2020-06-17 | | Release date: | 2016-01-13 | | Identifier: | N-[4-[[4-(4-methoxyphenyl)oxan-4-yl]methylcarbamoyl]phenyl]furan-2-carboxamide |
|
 | | AAD | | Name: | (2-AMINOOXY-ETHYL)-[5-(6-AMINO-PURIN-9-YL)-3,4-DIHYDROXY-TETRAHYDRO-FURAN-2-YLMETHYL]-METHYL-SULFONIUM | | Formula: | C13 H21 N6 O4 S | | SMILES: | n2c1c(ncnc1n(c2)C3OC(C(O)C3O)C[S+](CCON)C)N | | InChi: | InChI=1S/C13H21N6O4S/c1-24(3-2-22-15)4-7-9(20)10(21)13(23-7)19-6-18-8-11(14)16-5-17-12(8)19/h5-7,9-10,13,20-21H,2-4,15H2,1H3,(H2,14,16,17)/q+1/t7-,9+,10+,13+,24?/m0/s1 | | Synonyms: | 5'-[[2-(AMINOOXY)ETHYL]METHYLSULFONIO]-5'-DEOXY-ADENOSINE | | Definition date: | 2002-07-09 | | Last modified: | 2020-06-17 | | Identifier: | [2-(aminooxy)ethyl]{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}methylsulfonium (non-preferred name) |
|
 | | AB8 | | Name: | (1S,3R,8AS)-8-(2-{(4S,6S)-3-(4-HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)-2-OXOETHYL]-2-OXO-1,3-OXAZINAN-6-YL}ETHYL)-3
,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL (2R)-2-METHYLBUTANOATE | | Formula: | C34 H48 N2 O7 | | SMILES: | O=C(OC1C4C(=CC(C)C1)C=CC(C4CCC2OC(=O)N(C(C2)CC(=O)NC)Cc3ccc(O)c(OC)c3)C)C(C)CC | | InChi: | InChI=1S/C34H48N2O7/c1-7-21(3)33(39)43-30-15-20(2)14-24-10-8-22(4)27(32(24)30)12-11-26-17-25(18-31(38)35-5)36(34(40)42-26)19-23-9-13-28(37)29(16-23)41-6/h8-10,13-14,16,20-22,25-27,30,32,37H,7,11-12,15,17-19H2,1-6H3,(H,35,38)/t20-,21-,22-,25+,26+,27-,30-,32-/m0/s1 | | Synonyms: | LFA878 | | Definition date: | 2004-09-07 | | Last modified: | 2020-06-17 | | Identifier: | (1S,3R,7S,8S,8aR)-8-(2-{(4R,6R)-3-(4-hydroxy-3-methoxybenzyl)-4-[2-(methylamino)-2-oxoethyl]-2-oxo-1,3-oxazinan-6-yl}ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate |
|
 | | BYT | | Name: | Biocytin | | Formula: | C16 H28 N4 O4 S | | SMILES: | O=C1NC2C(SCC2N1)CCCCC(=O)NCCCCC(C(=O)O)N | | InChi: | InChI=1S/C16H28N4O4S/c17-10(15(22)23)5-3-4-8-18-13(21)7-2-1-6-12-14-11(9-25-12)19-16(24)20-14/h10-12,14H,1-9,17H2,(H,18,21)(H,22,23)(H2,19,20,24)/t10-,11-,12-,14-/m0/s1 | | Synonyms: | N~6~-{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}-L-lysine | | Definition date: | 2013-08-01 | | Last modified: | 2020-06-17 | | Release date: | 2014-09-10 | | Identifier: | N~6~-{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}-L-lysine |
|
 | | BYY | | Name: | 5-[(3aS,4S,6aR)-2-oxohexahydro-1H-selenopheno[3,4-d]imidazol-4-yl]pentanoic acid | | Formula: | C10 H16 N2 O3 Se | | SMILES: | O=C1NC2C(N1)C([Se]C2)CCCCC(O)=O | | InChi: | InChI=1S/C10H16N2O3Se/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1 | | Synonyms: | selenobiotin | | Definition date: | 2016-04-18 | | Last modified: | 2020-06-17 | | Release date: | 2016-11-16 | | Identifier: | 5-[(3aS,4S,6aR)-2-oxohexahydro-1H-selenopheno[3,4-d]imidazol-4-yl]pentanoic acid |
|
 | | BZ7 | | Name: | N~1~-{2-[([1,1'-biphenyl]-3-carbonyl)amino]ethyl}-N~4~-tert-butyl-N~2~-(3-phenylpropanoyl)-L-aspartamide | | Formula: | C32 H38 N4 O4 | | SMILES: | N(C(CC(NC(C)(C)C)=O)C(=O)NCCNC(=O)c1cccc(c1)c2ccccc2)C(CCc3ccccc3)=O | | InChi: | InChI=1S/C32H38N4O4/c1-32(2,3)36-29(38)22-27(35-28(37)18-17-23-11-6-4-7-12-23)31(40)34-20-19-33-30(39)26-16-10-15-25(21-26)24-13-8-5-9-14-24/h4-16,21,27H,17-20,22H2,1-3H3,(H,33,39)(H,34,40)(H,35,37)(H,36,38)/t27-/m0/s1 | | Synonyms: | PKS21004 | | Definition date: | 2017-09-05 | | Last modified: | 2020-06-17 | | Release date: | 2017-12-06 | | Identifier: | N~1~-{2-[([1,1'-biphenyl]-3-carbonyl)amino]ethyl}-N~4~-tert-butyl-N~2~-(3-phenylpropanoyl)-L-aspartamide |
|
 | | BZE | | Name: | 6-phenyl-1,3,5-triazine-2,4-diamine | | Formula: | C9 H9 N5 | | SMILES: | n1c(nc(nc1c2ccccc2)N)N | | InChi: | InChI=1S/C9H9N5/c10-8-12-7(13-9(11)14-8)6-4-2-1-3-5-6/h1-5H,(H4,10,11,12,13,14) | | Synonyms: | BENZOGUANAMINE | | Definition date: | 2013-05-10 | | Last modified: | 2020-06-17 | | Release date: | 2013-05-22 | | Identifier: | 6-phenyl-1,3,5-triazine-2,4-diamine |
|
 | | BZN | | Name: | N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide | | Formula: | C23 H32 N2 O3 S | | SMILES: | O=S(=O)(c1ccccc1)N(CC(C)C)CC3CNCC3COCc2ccccc2 | | InChi: | InChI=1S/C23H32N2O3S/c1-19(2)15-25(29(26,27)23-11-7-4-8-12-23)16-21-13-24-14-22(21)18-28-17-20-9-5-3-6-10-20/h3-12,19,21-22,24H,13-18H2,1-2H3/t21-,22-/m1/s1 | | Synonyms: | N-((3R,4R)-4-Benzyloxymethyl-pyrrolidin-3-ylmethyl)-N-isobutyl-benzene sulfonamide | | Definition date: | 2007-12-05 | | Last modified: | 2020-06-17 | | Identifier: | N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide |
|
 | | C01 | | Name: | (2S)-(4-ISOPROPYLPHENYL)[(2-METHYL-3-OXO-5,7-DIPROPYL-2,3-DIHYDRO-1,2-BENZISOXAZOL-6-YL)OXY]ACETATE | | Formula: | C25 H30 N O5 | | SMILES: | [O-]C(=O)C(Oc2c(cc1c(ON(C1=O)C)c2CCC)CCC)c3ccc(cc3)C(C)C | | InChi: | InChI=1S/C25H31NO5/c1-6-8-18-14-20-23(31-26(5)24(20)27)19(9-7-2)21(18)30-22(25(28)29)17-12-10-16(11-13-17)15(3)4/h10-15,22H,6-9H2,1-5H3,(H,28,29)/p-1/t22-/m0/s1 | | Synonyms: | ALPHA-ARYLOXYPHENYLACETIC ACID AGONIST | | Definition date: | 2005-04-26 | | Last modified: | 2020-06-17 | | Identifier: | (2S)-[4-(1-methylethyl)phenyl][(2-methyl-3-oxo-5,7-dipropyl-2,3-dihydro-1,2-benzisoxazol-6-yl)oxy]ethanoate |
|
 | | C09 | | Name: | 2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-4-amine | | Formula: | C13 H14 N4 O | | SMILES: | n3c1ccccc1c2c(nc(n2)COCC)c3N | | InChi: | InChI=1S/C13H14N4O/c1-2-18-7-10-16-11-8-5-3-4-6-9(8)15-13(14)12(11)17-10/h3-6H,2,7H2,1H3,(H2,14,15)(H,16,17) | | Synonyms: | CL097 | | Definition date: | 2013-01-22 | | Last modified: | 2020-06-17 | | Release date: | 2013-04-03 | | Identifier: | 2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-4-amine |
|
